Chronic kidney disease 10 years on: What have we learned?

Current Opinion in Nephrology and Hypertension

Volumn 21, Issue 6, 2012, Pages 607-611

  Taal, Maarten W ^a  

^a ROYAL DERBY HOSPITAL   (United Kingdom)

Author keywords

cardiovascular disease; chronic kidney disease; epidemiology; estimated glomerular filtration rate; risk prediction

Indexed keywords

CREATININE;

AWARENESS; CALIBRATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HUMAN; MATHEMATICAL MODEL; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; CREATININE; CYSTATIN C; GLOMERULAR FILTRATION RATE; HISTORY, 21ST CENTURY; HUMANS; KIDNEY; NEPHROLOGY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84868196896     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328358a30e     Document Type: Review

References (23)

1. Kidney Disease Outcomes Quality Initiative. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
2. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41:1-12.
3. Winearls CG, Glassock RJ. Dissecting and refining the staging of chronic kidney disease. Kidney Int 2009; 75:1009-1014.
4. Xu R, Zhang L, Zhang P, et al. Comparison of the prevalence of chronic kidney disease among different ethnicities: Beijing CKD survey and American NHANES. Nephrol Dial Transplant 2009; 24:1220-1226.
5. Gambaro G, Yabarek T, Graziani MS, et al. Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. Clin J Am Soc Nephrol 2010; 5:1946-1953.
6. Roderick P, Roth M, Mindell J. Prevalence of chronic kidney disease in England: findings from the 2009 Health Survey for England. J Epidemiol Comm Health 2011; 65:A12.
7. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298:2038-2047.
8. Stevens LA, Padala S, Levey AS. Advances in glomerular filtration rateestimating equations. Curr Opin Nephrol Hypertens 2010; 19:298-307.
9. McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW. Risk profile in chronic kidney disease stage 3: older versus younger patients. Nephron Clin Pract 2011; 119:c269-c276.
10. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011; 80:17-28.
11. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352:2049-2060.
12. Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367:20-29.
13. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
14. Hallan SI, Dahl K, Oien CM, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 2006; 333:1047.
15. Astor BC, Matsushita K, Gansevoort RT, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and endstage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011; 79:1331-1340.
16. Gansevoort RT, Matsushita K, van der Velde M, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes in both general and high-risk populations. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 2011; 80:93-104.
17. Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375:2073-2081.
18. Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011; 377:2181-2192.
19. Bang H, Vupputuri S, Shoham DA, et al. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med 2007; 167:374-381.
20. Halbesma N, Jansen DF, Heymans MW, et al. Development and validation of a general population renal risk score. Clin J Am Soc Nephrol 2011; 6:1731-1738.
21. Kshirsagar AV, Bang H, Bomback AS, et al. A simple algorithm to predict incident kidney disease. Arch Intern Med 2008; 168:2466-2473.
22. Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011; 305:1553-1559.
23. Weiner DE, Tighiouart H, Elsayed EF, et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol 2007; 50:217-224.